About WeGene
WeGene is a Healthcare company based in Shenzhen (China) founded in 2014. Genetic testing is conducted using saliva for health risk detection. Its website wegene.com draws about 34 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Applied Genomics and Consumer Genomics. Its competitors include CircleDNA, 23Mofang and GeseDNA; 2 of its 3 listed competitors have raised funding.
Company details
WeGene was founded in 2014 in Shenzhen, China, within the genetic testing sector. Saliva-based tests are utilized to identify sources of health risks, including hereditary and complex diseases, as well as drug reactions. Characteristics are analyzed to support avoidance of such conditions. The service is priced at 999 yuan, with funding raised from K2 Ventures. Operations focus on direct-to-consumer genetic analysis.
- Headquarters Shenzhen, China
- SectorsHealthcare
- Email••••••••
- Website wegene.com
- Social LinkedIn
- InvestorsK2
& 2 more
Funding Insights of WeGene
- Total Rounds 2
- Investors Count 3
All 2 funding rounds of WeGene with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | Series B | – | – | ||
| Aug 2015 | Seed | – | – |
3 investors in total: 3 institutional.
Investors in WeGene
WeGene has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include K2, Huada Gene and Ameba Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early and growth stage tech-focused VC firm investing primarily in China | amebacapital.com | Shanghai, China | ||
Genomics research and sequencing services are provided in China. | 1999 | genomics.cn | Shenzhen, China | |
Business process management platform provider | 2000 | k2.com | Bellevue, United States |
Investor details for WeGene
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of WeGene
3 dated milestones of WeGene across 4 years, from founding to its latest funding, stage changes and deals.
- Founded WeGene is founded.
- Funding First funding round.
- Funding Latest funding round, Series B,.
Competitors of WeGene
WeGene has 3 listed competitors in our database, 2 of them funded. They include CircleDNA, 23Mofang and GeseDNA.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| circledna.com | 2014 | Hong Kong, China | $15M | Internet-first platform for genetic diagnostics is provided. | ||
| 23mofang.com | 2015 | Chengdu, China | $34.25M | Provides genetic testing services to help prevent potential problems and early intervention. | ||
| gesedna.com | 2014 | Beijing, China | Gene detection tools and DNA interpretation services are provided. |
Detailed competitors of WeGene
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of WeGene
The website of WeGene (wegene.com) receives about 34.3K visits a month.
- Monthly visits34.3K
▼ 13.8% vs previous month
Websites whose visitors overlap most with WeGene. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| 23mofang.com | 100% | 102.8K | #301,987 | View details | |
theytree.com | theytree.com | 78% | #1,057,900 | – | |
santaihu.com | santaihu.com | 62% | #83,490 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Wegene
Complete news archive for WeGene
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about WeGene
WeGene was founded in 2014 and raised its 1st funding round 1 year after it was founded.
WeGene is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.
WeGene was founded in 2014 in Shenzhen, China, within the genetic testing sector. Saliva-based tests are utilized to identify sources of health risks, including hereditary and complex diseases, as well as drug reactions. Characteristics are analyzed to support avoidance of such conditions. The service is priced at 999 yuan, with funding raised from K2 Ventures. Operations focus on direct-to-consumer genetic analysis.
WeGene has 3 investors. Key investors include K2, Huada Gene, and Ameba Capital.